翔宇医疗(688626.SH)：2025年度净利润7869.90万元，同比减少23.55%

Core Viewpoint - Xiangyu Medical (688626.SH) reported a slight increase in total operating revenue for the fiscal year 2025, but experienced a significant decline in net profit attributable to the parent company [1] Financial Performance - The company achieved total operating revenue of 767.75 million yuan, representing a year-on-year growth of 3.26% [1] - The net profit attributable to the parent company was 78.70 million yuan, reflecting a year-on-year decrease of 23.55% [1] - The net profit attributable to the parent company after deducting non-recurring gains and losses was 58.95 million yuan, down 34.48% year-on-year [1] Operational Insights - The company focused on technological innovation and improving operational efficiency, which contributed to the slight revenue growth compared to the previous year [1] - There was an increase in expenses related to the recruitment of high-end rehabilitation technology talent, as well as rising salaries for research personnel [1] - The company also faced increased depreciation and amortization costs due to the ongoing use of construction projects, which negatively impacted net profit [1]